EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Helicobacter pylori Neutrophil Activating Protein (HP-NAP) Enhances the Anti-Leishmanial Activity of Canine Macrophages Against Leishmania infantum

Gaia Mazza iD, Federica Perego iD, Sara Coletta iD, Daniela Proverbio iD, Mario Milco D'Elios iD, Donatella Taramelli iD, Marina De Bernard iD, Fabrizio Bruschi iD, Nicoletta Basilico iD

Pathogens · 2026

DOI: 10.3390/pathogens15020184 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, 2026. Verfasst von Gaia Mazza und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical, Surgical and Dental Sciences, University of Milan, Via Pascal, 36, 20133 Milan, Italy. Hauptthemen laut MEDLINE: Leishmania infantum, Macrophages, Leishmaniasis, Visceral, Bacterial Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Milan, Università degli Studi di Milano, UNIMI GSA-IDEA Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Leishmania infantum is the etiological agent of visceral leishmaniasis (VL) and is linked to cases of cutaneous leishmaniasis in dogs. Dogs often develop severe systemic disease and serve as the primary reservoir of L. infantum. Although several vaccine candidates are under development, no vaccine for visceral leishmaniasis has been approved for human use to date. Chemotherapeutic treatment is hampered by toxicity, cost, and the emergence of parasite-resistant strains. Immunotherapy, combining chemotherapy with modulation of Th1 responses, is a promising therapeutic approach. Helicobacter pylori neutrophil-activating protein (HP-NAP), an immunomodulatory protein from Helicobacter pylori, is known to promote Th1 immune responses. A Th1 response activates macrophage promoting parasite killing, while a Th2 response favors disease progression. Macrophages are central for infection, either eliminating parasites (Th1 response) or supporting their persistence (Th2 response). IL-12 is a crucial cytokine in driving Th1 immunity and counteracting Th2 responses. We therefore investigated the role of HP-NAP in an in vitro model of L. infantum macrophage infection. Canine monocyte-derived macrophages from seven dogs were incubated with L. infantum promastigotes. More than 85% of macrophages from all donors were infected, with approximately seven amastigotes per cell. HP-NAP treatment significantly reduced all infection parameters and induced IL-12 production. Collectively, these findings suggest that HP-NAP may represent a promising candidate for adjuvant immunotherapies and vaccine development against L. infantum.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leishmania infantumMacrophagesLeishmaniasis, VisceralBacterial ProteinsHelicobacter pyloriAnimalsDogsTh1 CellsDog DiseasesInterleukin-12

Stichwörter der Autor:innen

Helicobacter pylori-neutrophil activating protein (HP-NAP)Leishmania infantumcanine macrophagescytokinesleishmaniasis

Substanzen

Bacterial Proteinsneutrophil-activating protein A, Helicobacter pyloriInterleukin-12

Autor:innen und Institutionen

  • Department of Biomedical, Surgical and Dental Sciences, University of Milan, Via Pascal, 36, 20133 Milan, Italy.
  • Department of Biology, University of Padova, Via Ugo Bassi, 58b, 35131 Padova, Italy.
  • Department of Veterinary Medicine and Animal Sciences, University of Milan, Via Dell' Università, 6, 26900 Lodi, Italy.
  • Department of Molecular and Developmental Medicine, University of Siena, Via Aldo Moro, 2, 53100 Siena, Italy.
  • Department of Pharmacological and Biomolecular Sciences, University of Milan, Via Pascal, 36, 20133 Milan, Italy.
  • Department of Translational Research, New Technologies in Medicine and Surgery, University of Pisa, Via Savi, 35, 56126 Pisa, Italy.

ORCID-Profile: Gaia Mazza, Federica Perego, Sara Coletta, Daniela Proverbio, Mario Milco D'Elios, Donatella Taramelli, Marina De Bernard, Fabrizio Bruschi, Nicoletta Basilico

Förderung

  • University of Milan
  • Università degli Studi di Milano
  • UNIMI GSA-IDEA Project

Zitieren

APA

Mazza, G., Perego, F., Coletta, S., Proverbio, D., D'Elios, M. M., Taramelli, D., De Bernard, M., Bruschi, F., & Basilico, N. (2026). Helicobacter pylori Neutrophil Activating Protein (HP-NAP) Enhances the Anti-Leishmanial Activity of Canine Macrophages Against Leishmania infantum. Pathogens. https://doi.org/10.3390/pathogens15020184

Vancouver

Mazza G, Perego F, Coletta S, Proverbio D, D'Elios MM, Taramelli D, et al. Helicobacter pylori Neutrophil Activating Protein (HP-NAP) Enhances the Anti-Leishmanial Activity of Canine Macrophages Against Leishmania infantum. Pathogens. 2026. doi:10.3390/pathogens15020184

BibTeX
@article{Mazza2026,
  author = {Mazza, Gaia and Perego, Federica and Coletta, Sara and Proverbio, Daniela and D'Elios, Mario Milco and Taramelli, Donatella and De Bernard, Marina and Bruschi, Fabrizio and Basilico, Nicoletta},
  title = {Helicobacter pylori Neutrophil Activating Protein (HP-NAP) Enhances the Anti-Leishmanial Activity of Canine Macrophages Against Leishmania infantum},
  journal = {Pathogens},
  year = {2026},
  doi = {10.3390/pathogens15020184}
}
Kostenlos starten →